These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 9766614
1. Clinical development of atypical antipsychotics: research design and evaluation. Collaborative Working Group on Clinical Trial Evaluations. J Clin Psychiatry; 1998; 59 Suppl 12():10-6. PubMed ID: 9766614 [Abstract] [Full Text] [Related]
3. Methodological and design issues in clinical trials of new neuroleptics: an overview. Awad AG. Br J Psychiatry Suppl; 1993 Dec; (22):51-7. PubMed ID: 7906524 [Abstract] [Full Text] [Related]
4. Dose selection and comparator drugs in schizophrenia research. Kane JM. J Clin Psychiatry; 2001 Dec; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828 [Abstract] [Full Text] [Related]
5. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia. Woods SW, Gueorguieva RV, Baker CB, Makuch RW. Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728 [Abstract] [Full Text] [Related]
6. Lessons learned from independent central review. Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J. Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138 [Abstract] [Full Text] [Related]
7. Iloperidone redux: a dissection of the Drug Approval Package for this newly commercialised second-generation antipsychotic. Citrome L. Int J Clin Pract; 2010 May; 64(6):707-18. PubMed ID: 20201991 [Abstract] [Full Text] [Related]
8. Placebo or active control trials of antipsychotic drugs? Fleischhacker WW, Czobor P, Hummer M, Kemmler G, Kohnen R, Volavka J. Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866 [Abstract] [Full Text] [Related]
9. Charging for investigational drugs under an investigational new drug application. Final rule. Food and Drug Administration, HHS. Fed Regist; 2009 Aug 13; 74(155):40871-900. PubMed ID: 19691172 [Abstract] [Full Text] [Related]
10. Expanded access to investigational drugs for treatment use. Final rule. Food and Drug Administration, HHS. Fed Regist; 2009 Aug 13; 74(155):40900-45. PubMed ID: 19691173 [Abstract] [Full Text] [Related]
13. Patient group seeks overhaul of FDA clinical trial system in court. Hede K. J Natl Cancer Inst; 2006 Sep 20; 98(18):1268-70. PubMed ID: 16985242 [No Abstract] [Full Text] [Related]
14. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program. Stark Y. Ann Neurol; 1994 Jul 20; 36(1):114-5. PubMed ID: 8024251 [No Abstract] [Full Text] [Related]